TMO

Thermo Fisher Scientific Inc.

HealthcareDiagnostics & ResearchNASDAQ

$492.51

+$47.28 (9.60%)today

Conviction

0/ 10

Fair Value$658.40

Upside+33.68%

Signal0

Market Cap$179.9B

52W Range$385.46–$643.99

Next EarningsApr 23

Price History

FAIR VALUE ANALYSISMonte Carlo · 3,000 runs · 99% valid

Fair Value$259.02

Current Price$470.00

Upside / Down-44.9%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)97.1%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

13.7%/yr

±5.2% · revenue growth to justify current price

FCF-Based Reverse DCF

20.0%/yr

±3.2% · FCF growth to justify current price

THE GAP

Market pricing margin compression or rising capex

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Thermo Fisher Scientific Inc.

Trailing P/E27.3x

Forward P/E18.0x

P/S4.0x

EPS (TTM)$17.74

Analyst Target$658.40

Analyst Upside33.7%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10kFeb 28

Conviction: unchanged

TMO FY2025 10-K: Bioproduction Thesis Intact, Tariff Headwinds in Analytical Instruments, Debt Load Rising

TMO delivered .6B in FY2025 revenue (+4%, +2% organic), adjusted EPS .87 (+5%), adjusted operating margin 22.7%. Life Sciences Solutions led growth driven by bioproduction recovery and Solventum filtr...